GENEVA, June 24 -- QILU PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/137985) for “STABLE PHARMACEUTICAL COMPOSITION OF ANTI-RANKL ANTIBODY”. With publication no. WO/2026/114292, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....